EN
登录

新疗法重新定义哮喘护理,改善患者健康

New Treatments Redefine Asthma Care, Improve Patient Health

CISION 等信源发布 2024-05-08 21:09

可切换为仅中文


Physician-authored paper highlights how innovative treatments can improve patient outcomes and why access is criticalWASHINGTON, May 8, 2024 /PRNewswire/ -- For decades, the inhaler has been the go-to treatment for asthma, but innovative options like biologics are changing how providers tailor care.'Breath of Fresh Care,' a physician-authored paper from the Alliance for Patient Access, highlights recent innovations in the field of asthma care.

医生撰写的论文强调了创新治疗如何改善患者的预后,以及为什么获得治疗至关重要华盛顿,2024年5月8日/PRNewswire/——几十年来,吸入器一直是治疗哮喘的首选方法,但生物制剂等创新选择正在改变提供者定制护理的方式。”来自患者获取联盟(Alliance for Patient Access)的一篇由医生撰写的论文《呼吸新鲜护理》(Breathe of Fresh Care)强调了哮喘护理领域的最新创新。

J. Allen Meadows, MD, discusses how innovative treatments are giving patients more targeted options that meet each patient's needs..

J、 医学博士艾伦·梅多斯(AllenMeadows)讨论了创新疗法如何为患者提供更有针对性的选择,以满足每位患者的需求。。

Continue Reading

继续阅读

Alliance for Patient Access logo. (PRNewsfoto/Alliance for Patient Access)

患者访问联盟徽标。(PRNewsfoto/患者访问联盟)

Making Asthma Care Accessible & Affordable

使哮喘护理易于获得和负担得起

While these treatments can be game changers for patients, access is critical. Barriers can get in the way, hindering patient care and harming the patient-provider relationship.

虽然这些治疗方法可能会改变患者的游戏规则,但获得治疗至关重要。障碍可能会阻碍患者护理,损害患者与提供者的关系。

Utilization management tactics like prior authorization and step therapy can prevent patients from accessing their treatment in a timely manner.

使用管理策略,如事先授权和分步治疗,可以防止患者及时获得治疗。

Pharmacy benefit managers may create formularies that exclude these treatments, forcing patients to use other, less effective medications.

药房福利经理可能会创建排除这些治疗的处方集,迫使患者使用其他效果较差的药物。

Copay diversion programs like alternative funding programs can complicate how patients access their medication and leave patients with significant out-of-pocket costs.

Copay转移计划(如替代资金计划)可能会使患者获得药物的方式复杂化,并使患者产生大量的自付费用。

Definitions of value from organizations like ICER may impact whether a medication receives coverage without weighing patient values and perspectives.

ICER等组织对价值的定义可能会影响药物是否在不权衡患者价值观和观点的情况下获得覆盖。

Policies that reduce these barriers can make a big difference. With the right care, asthma patients will be able to breathe easier.STATEMENT FROM J. ALLEN MEADOWS, MD: 'The right treatment can go a long way – it can reduce kids' absences at school, it can improve adults' productivity, it can reduce emergency room visits.

减少这些障碍的政策可以产生很大的影响。有了正确的护理,哮喘患者将能够呼吸更容易。J.的声明。艾伦·梅多斯(AllenMeadows),医学博士:“正确的治疗可以走很长的路——它可以减少孩子缺课,可以提高成年人的工作效率,可以减少急诊室的就诊次数。

It's amazing how far asthma treatments have come during my lifetime.'About the Alliance for Patient AccessThe Alliance for Patient Access is a network of policy-minded health care providers who advocate for patient-centered care.SOURCE Alliance for Patient Access.

在我的一生中,哮喘治疗取得了惊人的进展。”关于患者访问联盟患者访问联盟是一个由具有政策意识的医疗保健提供者组成的网络,他们倡导以患者为中心的护理。患者访问来源联盟。